Median Technologies obtains CE marking for lung cancer screening software

Median Technologies has received CE marking for its software designed to support lung cancer screening, enabling market access in the European Union.

• The CE marking certifies that the software meets relevant European health, safety, and environmental requirements for medical devices.
• The specific intended use and clinical performance data were not disclosed in the announcement.
• No information on whether the software incorporates AI or the type of imaging it analyzes was provided.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.